DLAT and hepatocellular carcinoma: These findings were consistent with previous observations linking high levels of DLAT expression to poor prognosis in pancreatic cancer,42 clear cell renal cell carcinoma,43 hepatocellular carcinoma,8, 44 and NSCLC.45